.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,716,198

« Back to Dashboard

Summary for Patent: 6,716,198

Title: Injection device
Abstract:An injection device for injecting set doses from an ampoule (2) mounted in the device, which doses are set by operation of a dose setting button (7) by which operation elastic torsion rods (14) positioned parallel with the longitudinal axis of the device are twisted. By the dose setting a torque is transmitted from the dose setting button (7) to the rods (14) through gear transmissions comprising a toothing (11) carried by a tubular (8) part coupled to the dose setting button (7) to rotate with this button. The toothing (11) engages pinions (13) fixed to the proximal ends of the torsion rods (14), which are made from a super elastic material, which can stand a deformation larger than 2% without being permanently deformed.
Inventor(s): Larsen; Andre (Drag.o slashed.r, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:09/853,818
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent Metrics:
Source: PatentQuant.com
Field: Medical technology
Back Citations: 13th percentile
Forward Citations: 3rd percentile

No matches for this query

Foreign Priority and PCT Information for Patent: 6,716,198

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark2000 00800May 18, 2000

International Patent Family for Patent: 6,716,198

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria303828► subscribe
Australia5824301► subscribe
Germany60113250► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc